These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 23350619)
1. Activatable cell penetrating peptide-conjugated nanoparticles with enhanced permeability for site-specific targeting delivery of anticancer drug. Xia H; Gu G; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Song Q; Yao L; Tu Y; Chen H; Gao X; Chen J Bioconjug Chem; 2013 Mar; 24(3):419-30. PubMed ID: 23350619 [TBL] [Abstract][Full Text] [Related]
2. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy. Gu G; Xia H; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Chen H; Gao X; Chen J Biomaterials; 2013 Jan; 34(1):196-208. PubMed ID: 23069707 [TBL] [Abstract][Full Text] [Related]
3. Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration. Xia H; Gao X; Gu G; Liu Z; Zeng N; Hu Q; Song Q; Yao L; Pang Z; Jiang X; Chen J; Chen H Biomaterials; 2011 Dec; 32(36):9888-98. PubMed ID: 21937105 [TBL] [Abstract][Full Text] [Related]
4. CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels. Hu Q; Gao X; Kang T; Feng X; Jiang D; Tu Y; Song Q; Yao L; Jiang X; Chen H; Chen J Biomaterials; 2013 Dec; 34(37):9496-508. PubMed ID: 24054848 [TBL] [Abstract][Full Text] [Related]
5. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors. Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250 [TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumor efficacy by d-glucosamine-functionalized and paclitaxel-loaded poly(ethylene glycol)-co-poly(trimethylene carbonate) polymer nanoparticles. Jiang X; Xin H; Gu J; Du F; Feng C; Xie Y; Fang X J Pharm Sci; 2014 May; 103(5):1487-96. PubMed ID: 24619482 [TBL] [Abstract][Full Text] [Related]
7. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells. Gu G; Gao X; Hu Q; Kang T; Liu Z; Jiang M; Miao D; Song Q; Yao L; Tu Y; Pang Z; Chen H; Jiang X; Chen J Biomaterials; 2013 Jul; 34(21):5138-48. PubMed ID: 23582684 [TBL] [Abstract][Full Text] [Related]
8. Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis. Huang S; Shao K; Liu Y; Kuang Y; Li J; An S; Guo Y; Ma H; Jiang C ACS Nano; 2013 Mar; 7(3):2860-71. PubMed ID: 23451830 [TBL] [Abstract][Full Text] [Related]
9. Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery. Xia H; Gao X; Gu G; Liu Z; Hu Q; Tu Y; Song Q; Yao L; Pang Z; Jiang X; Chen J; Chen H Int J Pharm; 2012 Oct; 436(1-2):840-50. PubMed ID: 22841849 [TBL] [Abstract][Full Text] [Related]
10. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth. Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853 [TBL] [Abstract][Full Text] [Related]
11. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419 [TBL] [Abstract][Full Text] [Related]
12. Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect. Wu J; Zhao J; Zhang B; Qian Y; Gao H; Yu Y; Wei Y; Yang Z; Jiang X; Pang Z Int J Nanomedicine; 2014; 9():5261-71. PubMed ID: 25419130 [TBL] [Abstract][Full Text] [Related]
13. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy. Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009 [TBL] [Abstract][Full Text] [Related]
14. UPA-sensitive ACPP-conjugated nanoparticles for multi-targeting therapy of brain glioma. Zhang B; Zhang Y; Liao Z; Jiang T; Zhao J; Tuo Y; She X; Shen S; Chen J; Zhang Q; Jiang X; Hu Y; Pang Z Biomaterials; 2015 Jan; 36():98-109. PubMed ID: 25443789 [TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer. Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689 [TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer. Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794 [TBL] [Abstract][Full Text] [Related]
17. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy. Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804 [TBL] [Abstract][Full Text] [Related]
18. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Guo J; Gao X; Su L; Xia H; Gu G; Pang Z; Jiang X; Yao L; Chen J; Chen H Biomaterials; 2011 Nov; 32(31):8010-20. PubMed ID: 21788069 [TBL] [Abstract][Full Text] [Related]
19. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043 [TBL] [Abstract][Full Text] [Related]
20. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]